First-Line Treatment of HER2-Positive Metastatic Breast Cancer

preview_player
Показать описание
Panelists discuss the combination of trastuzumab, pertuzumab, and docetaxel as frontline treatment for patients with HER2-positive metastatic breast cancer.

  1. OncLive
  2. cancer
  3. oncology
  4. Metastatic Breast Cancer (Disease Or Medical Condition)
  5. Metastasis (Disease Or Medical Condition)
  6. Medicine (Field Of Study)
Рекомендации по теме
First-Line Treatment of 0:06:08

First-Line Treatment of HER2-Positive Metastatic Breast Cancer

First-Line Treatment of 0:08:40

First-Line Treatment of HER2-Positive Metastatic Breast Cancer

Identifying drivers of 0:02:24

Identifying drivers of first-line HR+/HER2- metastatic breast cancer treatment choices

Medical update: HER2-Positive 0:51:38

Medical update: HER2-Positive and triple-positive metastatic breast cancer

Sequencing Treatment Options 0:02:43

Sequencing Treatment Options in HER2 Positive Breast Cancer: 2023 Best of Breast Conference

Combination Treatment of 0:06:40

Combination Treatment of HER2+ Metastatic Breast Cancer: First-Line Therapy

Management of HER2 0:04:01

Management of HER2 positive metastatic breast cancer treatment algorithm

Treatment strategies for 0:02:15

Treatment strategies for HER2+ metastatic breast cancer

First-line Therapy for 0:07:34

First-line Therapy for HR-positive, HER2-negative, mBC

First-line camizestrant for 0:00:52

First-line camizestrant for ER+/HER2- advanced breast cancer

Treatment Updated for 0:30:57

Treatment Updated for HER2 Positive Breast Cancer: Changing Paradigms

The evolution of 0:02:09

The evolution of HER2 targeting in metastatic breast breast cancer

First-Line ER-Positive Metastatic 0:05:32

First-Line ER-Positive Metastatic Breast Cancer Treatments

Treatment for HER2+ 0:01:39

Treatment for HER2+ metastatic breast cancer

HER2+ Breast Cancer: 0:03:44

HER2+ Breast Cancer: Brain Metastasis Prevalence & Later-Line Therapy

Current Treatment Options 0:01:31

Current Treatment Options for Patients With HER2-Positive Metastatic Breast Cancer

Treatment Options in 0:06:46

Treatment Options in HER2+ Metastatic Breast Cancer

Study of Targeted 0:03:19

Study of Targeted Therapy for HER2-Positive Metastatic Breast Cancer

Frontline T-DM1 in 0:03:58

Frontline T-DM1 in HER2-Positive Metastatic Breast Cancer

Frontline Pertuzumab for 0:06:00

Frontline Pertuzumab for Metastatic Breast Cancer

Dr Bardia on 0:01:27

Dr Bardia on Current Approaches to HER2+ Breast Cancer Management

Combination Treatment of 0:06:46

Combination Treatment of HER2+ Metastatic Breast Cancer: First-Line Therapy

Optimizing Therapy in 0:47:29

Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani

Poziotinib for HER2-positive 0:01:29

Poziotinib for HER2-positive metastatic breast cancer